Abstract
Mansonic schistosomiasis is a cronic and debilitant disease. In Brazil is estimated from 8 to 10 million infected people. Treatment is based in chemotherapy using praziquantel. Unfortunately, the excessive and inappropriate use of this drug has culminated in parasite resistance and worry about disease control, and the development of new alternatives is being requested, and to solve these …